Search
for
Sort by
Research 301–330 of 1000+
- Androgen treatment in women
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- How should postmenopausal androgen excess be evaluated?
- Cardiovascular risk factors and events in women with androgen excess
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men
- Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Testosterone metabolite nonessential for androgen effects
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays
- Is COVID-19 Gender-sensitive?
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Anti-Androgens
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Antiandrogen therapy for androgenetic alopecia
- GC-MS determination of steroids related to androgen biosynthesis in human hair with pentafluorophenyldimethylsilyl–trimethylsilyl derivatisation
- Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens)
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Role of Androgen Receptor in Hypothalamic Regulation of Metabolism and Reproduction
- Managing polycystic ovary syndrome in primary care
- Structure of human type II 5 alpha-reductase gene.
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Androgen insufficiency in women: diagnostic and therapeutic implications